1. Dasatinib plus Peg‐Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA‐PegIFN study). (10th October 2022) Authors: Roy, Lydia; Chomel, Jean‐Claude; Guilhot, Joëlle; Guerci‐Bresler, Agnès; Escoffre‐Barbe, Martine; Giraudier, Stéphane; Charbonnier, Aude; Dubruille, Viviane; Huguet, Françoise; Johnson‐Ansah, Hyacinthe; Lenain, Pascal; Ame, Shanti; Etienne, Gabriel; Nicolini, Franck E.; Rea, Delphine; Cony‐Makhou... Journal: British journal of haematology Issue: Volume 200:Number 2(2023) Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B‐cell lymphoma in first relapse: results of the R‐NIMP GOELAMS study. (21st May 2013) Authors: Gyan, Emmanuel; Damotte, Diane; Courby, Stéphane; Sénécal, Delphine; Quittet, Philippe; Schmidt‐Tanguy, Aline; Banos, Anne; Le, Steven; Lamy, Thierry; Fontan, Jean; Maisonneuve, Hervé; Alexis, Magda; Dreyfus, Francois; Tournilhac, Olivier; Laribi, Kamel; Solal‐Céligny, Philippe; Arakelyan, Nina; ... Journal: British journal of haematology Issue: Volume 162:Number 2(2013:Jul.) Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗